Literature DB >> 11033305

Spheroids in radiobiology and photodynamic therapy.

C Dubessy1, J M Merlin, C Marchal, F Guillemin.   

Abstract

Spheroids are tridimensional aggregates of tumor cells coming from one or several cell clones. This model, which mimics the micro-tumors structure and some of their properties, shows oxygen, pH and nutrient gradients inducing a necrotic area in the center of the spheroid. Analysis of spheroids, cultured under static or stirred conditions, can be performed on whole spheroids or dissociated spheroids. The spheroids sensitivity to ionizing radiation and photodynamic therapy can be altered by oxygen status, damage repair, intercellular commmunications and apoptosis induction, as in experimental tumor models. In radiobiology, the similarity of radiation response between spheroids and tumor xenograft bearing mice makes the spheroids to be a good alternative model to in vivo irradiation studies. In photodynamic therapy, spheroids lead to a better understanding of the own tumor response without interactions with vascular system. Finally, despite the quality of spheroid model, only the use of new technology for analysis of spheroid populations will help to increase their experimental use, particularly in preclinical oncology.

Entities:  

Mesh:

Year:  2000        PMID: 11033305     DOI: 10.1016/s1040-8428(00)00085-8

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  39 in total

Review 1.  Development of radiotracers for oncology--the interface with pharmacology.

Authors:  Rohini Sharma; Eric Aboagye
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  Spheroid-based drug screen: considerations and practical approach.

Authors:  Juergen Friedrich; Claudia Seidel; Reinhard Ebner; Leoni A Kunz-Schughart
Journal:  Nat Protoc       Date:  2009-02-12       Impact factor: 13.491

3.  Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids.

Authors:  Hari R Kumar; Xiaoling Zhong; Derek J Hoelz; Frederick J Rescorla; Robert J Hickey; Linda H Malkas; John A Sandoval
Journal:  Pediatr Surg Int       Date:  2008-09-17       Impact factor: 1.827

4.  A549 and MRC-5 cell aggregation in a microfluidic Lab-on-a-chip system.

Authors:  A Zuchowska; E Jastrzebska; K Zukowski; M Chudy; A Dybko; Z Brzozka
Journal:  Biomicrofluidics       Date:  2017-03-28       Impact factor: 2.800

5.  Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.

Authors:  Kazuhide Sato; Rira Watanabe; Hirofumi Hanaoka; Toshiko Harada; Takahito Nakajima; Insook Kim; Chang H Paik; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Oncol       Date:  2014-01-22       Impact factor: 6.603

Review 6.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

7.  Continuously perfused microbubble array for 3D tumor spheroid model.

Authors:  Sivaprakash Agastin; Ut-Binh T Giang; Yue Geng; Lisa A Delouise; Michael R King
Journal:  Biomicrofluidics       Date:  2011-06-03       Impact factor: 2.800

8.  ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.

Authors:  J O Humtsoe; E Pham; R J Louie; D A Chan; R H Kramer
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

Review 9.  Organ-on-a-chip platforms for studying drug delivery systems.

Authors:  Nupura S Bhise; João Ribas; Vijayan Manoharan; Yu Shrike Zhang; Alessandro Polini; Solange Massa; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

10.  New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.

Authors:  Galina I Botchkina; Edison S Zuniga; Manisha Das; Yuan Wang; Hichao Wang; Shu Zhu; Anne G Savitt; Rebecca A Rowehl; Yan Leyfman; Jingfang Ju; Kenneth Shroyer; Iwao Ojima
Journal:  Mol Cancer       Date:  2010-07-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.